NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
31 March 2026
Recommended Cash Offer
for
essensys plc ("essensys")
by
essensys Bidco Limited ("Bidco")
Day 21 acceptance level update
Introduction
On 24 February 2026, Bidco and the essensys Independent Directors announced that they had reached agreement on the terms of a recommended cash offer for the entire issued and to be issued ordinary share capital of essensys by Bidco (other than those essensys Shares held by or contracted to be acquired by or on behalf of Bidco) at a price of 17 pence per essensys Share (the "Offer").
On 9 March 2026, Bidco and the essensys Independent Directors announced that the offer document in relation to the Offer (the "Offer Document"), containing, among other things, a letter from the independent committee of essensys, a letter from the sole director of Bidco, the full terms and Conditions of the Offer, an expected timetable of principal events and details of the action to be taken by essensys Shareholders, were published, posted and made available to essensys Shareholders (other than essensys Shareholders resident or located in a Restricted Jurisdiction).
A copy of the Offer Document is available on essensys's website at: https://www.essensys.tech.
This announcement (this "Announcement") should be read in conjunction with the full text of the Offer Document. Capitalised terms used in this Announcement, unless otherwise defined, have the same meanings as set out in the Offer Document.
Day 21 acceptance level update
Day 60 of the Offer timetable will be 8 May 2026. Day 21 of the Offer timetable was therefore 30 March 2026.
In accordance with Rule 17 of the Takeover Code, Bidco confirms that, as at 1.00 p.m. on 30 March 2026, valid acceptances of the Offer ("Valid Acceptances") had been received in respect of a total of 112,106 essensys Shares, representing 0.27 per cent. of essensys's existing issued ordinary share capital, which Bidco may count towards the satisfaction of the Acceptance Condition.
As described in paragraph 7 of Part 6 (Additional Information) of the Offer Document, Bidco received indications of support to accept, or procure or instruct the acceptance of the Offer in respect of a total of 13,307,993 essensys Shares, representing approximately 20.52 per cent. of essensys's existing issued ordinary share capital. So far as Bidco is aware, these commitments remain outstanding as at 1.00 p.m. on 30 March 2026. As such, none of the abovementioned Valid Acceptances are in respect of the essensys Shares that were (i) the subject of irrevocable undertakings or a letter of intent to accept (or procure the acceptance of) the Offer, given by the essensys Directors and certain essensys Shareholders in respect of their own entire legal and beneficial holdings of essensys Shares (or those essensys Shares over which they have control); or (ii) received from persons acting in concert with Bidco.
Together with the commitments Bidco has received under the Bidco SPAs, Bidco received indications of support to accept, or procure or instruct the acceptance of the Offer in respect of a total of 36,994,705 essensys Shares, representing approximately 57.04 per cent. of the existing ordinary share capital of essensys.
Bidco is aware that essensys Shareholders providing irrevocable undertakings are in contact with their nominees and investment platforms to procure acceptance of the Offer in accordance with the terms of their respective undertakings and, further, that such essensys Shareholders are experiencing delays in corporate actions being made available and, in some circumstances, delays in rematerialising their essensys Shares in order to elect to accept the Alternative Offer. Further updates will be provided in due course.
Further details of the irrevocable undertakings and the letter of intent, including the terms on which the irrevocable undertakings cease to be binding are set out in paragraph 7 of Part 6 (Additional Information) of the Offer Document.
Interests in securities
As at 6.00 p.m. on 30 March 2026, and save as disclosed in the Offer Document (including in relation to the 23,686,712 essensys Shares subject to the terms of the Bidco SPAs), neither Bidco, nor the sole director of Bidco, nor, so far as the sole director of Bidco is aware, any other person acting, or deemed to be acting, in concert with Bidco:
· held any interest in, or right to subscribe for, or any short position in respect of (whether conditional or absolute and whether in the money or otherwise), including any short position under a derivative, any agreement to sell or any delivery obligation or right to require another person to purchase or take delivery, any relevant securities of essensys;
· had borrowed or lent any relevant securities of essensys, save for any borrowed shares which have been either on-lent or sold (including for these purposes any financial collateral arrangements of the kind referred to in Note 3 on Rule 4.6 of the Takeover Code); or
· had procured an irrevocable commitment or letter of intent to accept the terms of the Offer in respect of relevant securities of essensys.
In this paragraph, "relevant securities of essensys" means essensys Shares and securities convertible into, or rights to subscribe for, options (including traded options) in respect thereof and derivatives referenced thereto.
Acceptance Condition
As at 1.00 p.m. on 30 March 2026, Bidco may count 112,106 essensys Shares, representing approximately 0.27 per cent. of essensys's existing issued ordinary share capital, towards satisfaction of the Acceptance Condition.
essensys Shareholders are reminded that, as a summary and subject to the fuller description in the Offer Document, the Acceptance Condition shall be satisfied should Bidco receive Valid Acceptances and/or Bidco or an entity controlled by Bidco acquire or agree to acquire essensys Shares which, excluding essensys Shares to be sold pursuant to the Bidco SPAs, in aggregate represent more than 90 per cent. of the essensys Shares to which the Offer relates.
The percentages of essensys Shares referred to in this Announcement are based on the figure of 64,856,026 ordinary essensys Shares in issue at 1.00 p.m. on 30 March 2026 (being the last Business Day prior to the date of this Announcement).
Action to be taken by essensys Shareholders to accept the Offer
The Offer will be open for acceptance until 1.00 p.m. on 8 May 2026, unless the Unconditional Date is brought forward or extended by Bidco in accordance with the Takeover Code and as further described in paragraph 1 of Section F of Part 3 (Conditions and Further Terms of the Offer) of the Offer Document.
essensys Shareholders who have not yet accepted the Offer are encouraged to do so as soon as possible.
The procedures for acceptance of the Cash Offer and, for those who wish to do so (other than essensys Shareholders resident or located in a Restricted Jurisdiction), to elect for the Alternative Offer, are set out in paragraph 16 of Part 2 (Letter from essensys Bidco Limited) of the Offer Document. Acceptances of the Offer in respect of essensys Shares held in certificated form (that is, not in CREST) should be made by completing and returning the Form of Acceptance accompanying the Offer Document, together with the share certificate(s) and/or other documents of title, as soon as possible and in any event so as to be received by the Receiving Agent, Equiniti Limited, by no later than 1.00 p.m. on the Unconditional Date. Acceptances in respect of uncertificated essensys Shares (that is, in CREST) should be made electronically through CREST so that the TTE Instruction settles as soon as possible, and in any event, no later than 1.00 p.m. on the Unconditional Date. If essensys Shareholders are a CREST sponsored member, they should refer to their CREST sponsor as only their CREST sponsor will be able to send the necessary TTE Instruction(s) to Euroclear.
essensys Shareholders who are holding their essensys Shares through an investment platform may be required to rematerialise their essensys Shares into certificated form if they wish to elect to accept the Alternative Offer. Such essensys Shareholders should contact Equiniti on +44 (0)371 384 2050 for further information as soon as possible.
Further details of how to accept the Offer are set out in the Offer Document.
Cancellation of trading, squeeze-out and re-registration
essensys Shareholders are reminded that, as stated in the Offer Document, after the Offer becomes or is declared unconditional and if Bidco has, by virtue of its shareholdings and acceptances of the Offer, acquired or agreed to acquire essensys Shares carrying 90 per cent. or more of the voting rights of essensys, it is intended that Bidco shall procure that essensys makes a request to the London Stock Exchange for the cancellation of the admission to trading of essensys Shares on AIM. It is anticipated that such cancellation will take effect no earlier than 20 Business Days after the Offer becomes or is declared unconditional, subject to compliance with applicable requirements of the AIM Rules. The cancellation of the trading of the essensys Shares will significantly reduce the liquidity and marketability of any essensys Shares not assented to the Offer and their value may be affected in consequence.
It is also intended that, following the Offer becoming or being declared unconditional, assuming the cancellation of trading of essensys Shares on AIM, Bidco will procure that essensys is re-registered as a private limited company under the relevant provisions of the Companies Act.
If Bidco receives acceptances under the Offer in respect of, and/or otherwise acquires, 90 per cent. or more of essensys Shares to which the Offer relates, and assuming that all of the other Conditions have been satisfied or waived (if capable of being waived), Bidco intends to exercise its rights pursuant to sections 974 - 991 of the Companies Act to acquire compulsorily any essensys Shares not acquired or agreed to be acquired by or on behalf of Bidco pursuant to the Offer or otherwise on the same terms as the Offer.
Currency and settlement
Each essensys Shareholder electing for the Cash Offer will receive the Cash Consideration which is payable to them under the Offer in respect of their essensys Shares in pounds Sterling. Each essensys Shareholder electing for the Alternative Offer will be issued the New Bidco Shares in certificated form.
Subject to the Offer becoming or being declared unconditional, settlement for those essensys Shareholders who have validly accepted the Offer on or before the Offer becoming or being declared unconditional will be effected within 14 calendar days of the Offer becoming or being declared unconditional or, in relation to Valid Acceptances received after this date, within 14 calendar days of receipt of that acceptance.
Those essensys Shareholders should refer to the provisions at paragraph 17 of Part 2 (Letter from essensys Bidco Limited) of the Offer Document.
This section should be read in conjunction with Offer Document and, in the case of essensys Shares held in certificated form, the Form of Acceptance. essensys Shareholders are recommended to seek their own personal independent financial advice immediately from their stockbroker, bank manager, solicitor, accountant or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if they are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.
Questions
If essensys Shareholders have any questions about this Announcement or the Offer Document, or are in any doubt as to how to complete the Form of Acceptance (if they hold essensys Shares in certificated form) or as to how to make an Electronic Acceptance (if they hold essensys Shares in uncertificated form), or wish to obtain an additional Form of Acceptance, please contact the Receiving Agent, Equiniti, on +44 (0)371 384 2050 or by submitting a request in writing to the Receiving Agent at Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the United Kingdom will be charged at the applicable international rate. Lines are open between 8.30 a.m. to 5.30 p.m., Monday to Friday (except public holidays in England and Wales). Please note that the Receiving Agent cannot provide any financial, legal or tax advice and calls may be recorded and monitored for security and training purposes.
Enquiries:
|
essensys Bidco Limited |
+44 (0) 203 102 5256 |
|
Mark Furness |
|
|
Kroll Securities Limited (Financial Adviser to Bidco) |
+44 (0) 020 7089 4700 |
|
Rory O'Sullivan / Joseph Smart |
|
|
essensys plc |
+44 (0)20 3102 5252 |
|
James Lowery, Chief Executive Officer |
|
|
Greg Price, Chief Financial Officer |
|
|
Canaccord Genuity Limited (Financial Adviser, Nominated Adviser and Corporate Broker to essensys) |
+44 (0)20 7523 8000 |
|
Simon Bridges / Harry Gooden / Andrew Potts / Elizabeth Halley-Stott |
|
|
Gracechurch Group (Financial PR & IR Adviser to essensys) |
+44 (0) 20 4582 3500 |
|
Heather Armstrong / Alexis Gore / Rebecca Scott |
essensys@gracechurchpr.com |
Reed Smith LLP is retained as legal adviser to Bidco. Osborne Clarke LLP is retained as legal adviser to essensys.
Important notices
Kroll Securities Limited ("Kroll"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom (the "FCA"), is acting exclusively for Bidco and no one else in connection with the Acquisition and/or any other matter referred to in this Announcement and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Bidco for providing the protections afforded to clients of Kroll, nor for providing advice in relation to the Acquisition or any matter referred to herein. Neither Kroll nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Kroll in connection with this Announcement, any statement contained herein or otherwise.
Canaccord Genuity Limited ("Canaccord Genuity"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for essensys and for no one else in connection with the Acquisition and/or any other matter referred to in this Announcement and will not be responsible to anyone other than essensys for providing the protections afforded to clients of Canaccord Genuity or for providing advice in relation to the matters referred to herein. Neither Canaccord Genuity nor any of its affiliates (nor any of its or their respective directors, officers, employees, representatives or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Canaccord Genuity in connection with this Announcement, any statement contained herein or otherwise.
This Announcement is for information purposes only and does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities, or the solicitation of any vote or approval in any jurisdiction in which such offer or solicitation is unlawful, pursuant to the Acquisition or otherwise. The Acquisition is being made solely by means of the Offer Document (or in the event, with the consent of the Panel, that the Acquisition is to be implemented by means of a Scheme, the scheme document) and the Form of Acceptance (in respect of certificated essensys Shares) which contains the full terms and Conditions of the Acquisition, including details of how the Offer may be accepted.
This Announcement has been prepared for the purpose of complying with English law and the Takeover Code and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.
The full terms and conditions of the Offer (including details of how the Offer may be accepted) are set out in the Offer Document and, in the case of certificated essensys Shares, the related Form of Acceptance. The Offer is being made solely through the Offer Document and, in the case of certificated essensys Shares, the Form of Acceptance, and any acceptance of the Offer should be made only on the basis of the information contained in the Offer Document and, in the case of certificated essensys Shares, the Form of Acceptance.
Overseas Shareholders
The release, publication or distribution of this Announcement and the issue of the New Bidco Shares issued under the Alternative Offer in jurisdictions other than the United Kingdom may be restricted by law and/or regulations. No action has been taken by essensys or Bidco to obtain any approval, authorisation or exemption to permit the issue of the New Bidco Shares under the Alternative Offer possession or distribution of this Announcement (or any other publicity material relating to the New Bidco Shares) in any jurisdiction, other than in the United Kingdom.
It is the responsibility of any Overseas Shareholders to satisfy themselves as to the full observance of the laws and regulations of the relevant jurisdiction in connection therewith, including the obtaining of any governmental, exchange control or other consents which may be required, the compliance with other necessary formalities and the payment of any issue, transfer or other taxes or duties or payments due in such jurisdiction. Any failure to comply with such restrictions or requirements may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person.
Unless otherwise determined by Bidco or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition and the New Bidco Shares issued under the Alternative Offer shall not be made available, in whole or in part, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws or regulations in that jurisdiction and no person may vote in favour of the Acquisition by any such use, means, instrumentality or form within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this Announcement and all documents relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction and persons receiving this Announcement and all documents relating to the Acquisition (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from any Restricted Jurisdiction. Doing so may render invalid any purported acceptance of the Offer.
The Acquisition is subject to the applicable requirements of, the Takeover Code, the Panel, the London Stock Exchange and the AIM Rules.
Further details in relation to Overseas Shareholders are contained in the Offer Document.
Additional information for US investors
The Offer relates to the shares of an English company and is being made by means of a contractual takeover offer under the Takeover Code and under the laws of England and Wales. The Cash Offer will be made in the United States pursuant to all applicable laws and regulations, including, to the extent applicable, Section 14(e) and Regulation 14E under the US Exchange Act and otherwise in accordance with the requirements of the Takeover Code. Accordingly, the Cash Offer will be subject to the disclosure and other procedural requirements, including with respect to withdrawal rights, offer timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer procedures and law. US holders of essensys Shares should note that essensys is not listed on a US securities exchange and is not subject to the periodic reporting requirements of the US Exchange Act, and is not required to, and does not, file any reports with the US Securities and Exchange Commission thereunder. The Cash Offer will be made in the United States by Bidco and no one else.
If, in the future, Bidco exercises its right to implement the Cash Offer by way of a Scheme, which is to be made into the United States, such Scheme will be made in compliance with the applicable U.S. law and regulation.
Furthermore, the payment and settlement procedure with respect to the Cash Offer will comply with the relevant United Kingdom rules, which differ from US payment and settlement procedures, particularly with regard to the date of payment of consideration.
essensys Shareholders located or resident in the US (or who are otherwise US persons as such term is defined in Regulation S under the US Securities Act) will not be permitted to elect receipt of the New Bidco Shares pursuant to the Alternative Offer. No offer of such New Bidco Shares is being made in the US, and any purported election to receive New Bidco Shares pursuant to the Alternative Offer by essensys Shareholders from the US, or which, at the sole discretion of Bidco, appear to be made in respect of essensys Shares beneficially held by persons located or resident in the US or who otherwise appear to be US persons will not be accepted. Accordingly, essensys Shareholders located or resident in the US or who are otherwise US persons will receive cash pursuant to the Cash Offer, and no New Bidco Shares will be issued to any such essensys Shareholder. The New Bidco Shares have not been and will not be registered under the US Securities Act or under US securities laws, and will not be listed on any stock exchange in the US, and may not be offered, sold or delivered, directly or indirectly, in, into or from the US absent registration or an applicable exemption from registration requirements of the US Securities Act and applicable state securities laws.
Non-US essensys Shareholders will be deemed, by electing receipt of the New Bidco Shares pursuant to the Alternative Offer, to represent and warrant, on behalf of themselves and any person on whose behalf they beneficially hold their essensys Shares, that they: (i) are not located or resident in the US or otherwise a US person; and (ii) are not electing receipt of New Bidco Shares pursuant to the Alternative Offer with a view to, or for offer or sale of New Bidco Shares in connection with, any distribution thereof (within the meaning of the US Securities Act) in the US or to US persons.
In accordance with, and to the extent permitted by, the Takeover Code and normal UK market practice, Bidco, its affiliates, their advisors and nominees or brokers (acting as agents) may make certain purchases of, or arrangements to purchase, essensys Shares outside the Offer, such as in open market purchases or privately negotiated purchases, during the offer period and the period in which the Offer remains open for acceptance. If such purchases or arrangements to purchase were to be made, they would be made outside the US and would comply with applicable law and regulation, including those of the United Kingdom and the US Exchange Act. Any such purchases by Bidco or its affiliates will not be made at prices higher than the price of the Offer provided in this Announcement unless the price of the Offer is increased accordingly. Any information about such purchases or arrangements to purchase shall be disclosed as required under United Kingdom laws and will be available to all investors (including US investors) via the Regulatory Information Service and shall be available on the London Stock Exchange website at www.londonstockexchange.com. To the extent that such information is required to be publicly disclosed in the United Kingdom in accordance with applicable regulatory requirements, this information will, as applicable, also be publicly disclosed in the United States.
It may be difficult for US holders of essensys Shares to enforce their rights and any claim arising out of the US securities laws in connection with the Offer, since Bidco and essensys are located in a non-US jurisdiction, and some or all of their officers and directors may be residents of a non-US jurisdiction. US holders of essensys Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement.
The financial information included in this Announcement has been prepared in accordance with accounting standards applicable in the United Kingdom and thus may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the US ("US GAAP"). US GAAP differs in certain significant respects from accounting standards applicable in the United Kingdom. None of the financial information in this Announcement has been audited in accordance with auditing standards generally accepted in the United States or the auditing standards of the Public Company Accounting Oversight Board (United States).
Neither the Offer nor this Announcement have been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any other US regulatory authority, nor have such authorities approved or disapproved or passed judgement upon the fairness or the merits of the Offer or the New Bidco Shares, or determined if the information contained in this Announcement is adequate, accurate or complete. Any representation to the contrary is a criminal offence in the United States. The receipt of cash pursuant to the Cash Offer by a US holder as consideration for the transfer of its essensys Shares pursuant to the Cash Offer will likely be a taxable transaction for US federal (and applicable state and local) income tax purposes. EACH US HOLDER IS URGED TO CONSULT THEIR TAX ADVISOR REGARDING THE TAX CONSEQUENCES TO THEM OF THE RECEIPT OF CASH IN EXCHANGE FOR THEIR ESSENSYS SHARES PURSUANT TO THE CASH OFFER.
Disclosure requirements of the Takeover Code
Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of: (i) the offeree company; and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th Business Day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.
Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of: (i) the offeree company; and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant dealing.
If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).
Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.
Electronic communications
Please be aware that addresses, electronic addresses and certain information provided by essensys Shareholders and other relevant persons for the receipt of communications from essensys may be provided to Bidco during the Offer Period as requested under Section 4 of Appendix IV of the Takeover Code to comply with Rule 2.11(c) of the Takeover Code.
Publication on website and availability of hard copies
A copy of this Announcement will be made available free of charge (subject to certain restrictions relating to persons resident in Restricted Jurisdictions) on essensys's website at https://www.essensys.tech, by no later than 12 noon (London time) on the Business Day following this Announcement. For the avoidance of doubt, neither the content of this website nor of any website accessible from any hyperlinks set out in this Announcement are incorporated into or form part of this Announcement.
essensys Shareholders may also request that all future documents, announcements and information to be sent to them in relation to the Acquisition should be in hard copy form by writing to Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA or by calling Equiniti Limited on telephone number +44 (0)371 384 2050 between 8.30 a.m. and 5.30 p.m., Monday to Friday (excluding public holidays). If you have received this Announcement in electronic form, copies of this Announcement and any document or information incorporated by reference into this Announcement will not be provided unless such a request is made.
General
If essensys Shareholders are in any doubt about the contents of this Announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are a resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.
Time
All references to time in this Announcement are to London (UK) time, unless otherwise stated.